Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
878.00    -14.80 (-1.66%)
Bid:
877.80
Ask:
878.40
Spread: 0.60 (0.068%)
Market Cap: £11.02b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Market Update

20 Jan 2026 07:00

RNS Number : 5115P
Informa PLC
20 January 2026
 

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC: Market Update

20 January 2026

Growth in 2025, Compounding Growth in 2026

Market-leading brands, international reach and structural strength delivering consistent strong growth

Informa (LSE: INF.L), the international B2B Events, B2B Digital Services and Academic Markets Group, today published a Market Update, confirming strong trading through 2025, 6%± underlying revenue guidance for 2026 and £200m of new share buybacks, whilst being recognised as one of Britain's Most Admired Companies in the latest annual study sponsored by The London Stock Exchange. Separately, the Group also launched its partnership with Dubai World Trade Centre ("DWTC").

Stephen A. Carter, Group Chief Executive, Informa, said:

"2025 was a strong year for Informa and we have set ourselves the target of delivering another strong performance year in 2026."

He added: "Across the world, the Power of Live is driving strong demand for our B2B brands, whilst ongoing growth in specialist research is underpinning the strength of our academic business. First party data, AI development and international expansion continue to create new growth opportunities, including through our UAE partnership Informa International, that launches today as a separate operating business, inD."

He concluded: "Recognition in the annual study of Britain's Most Admired Companies reflects just how far Informa has come over the last 15+ years and is testament to the unwavering commitment of Colleagues, the creativity of our Partners, the consistent support of Shareholders and the progressive internationalisation of the Group."

Double-Digit Growth Confirmed in 2025

· Full Year outcome…Strong trading through Q4 2025, particularly in Live B2B Events, is expected to deliver full year results in line with or ahead of market guidance:

Double-digit growth in Revenues… Group Revenues are expected to be £4.0bn+, delivering year-on-year reported revenue growth of 12.5%+, underlying revenue growth of 6.25%± and 8%± underlying growth absent TechTarget consolidation and non-recurring LLM contracts;

Double-digit growth in Earnings…Adjusted EPS is expected to be 55.5p±, a year-on-year increase of 10.5% to 11% and 15%+ absent FX movements and non-recurring data contracts;

Growth in Free Cashflow... Adjusted Free Cashflow is expected to be £860m+, delivering further year-on-year growth and funding investment in the One Informa growth programme; Operating cash discipline remains a key focus, with ongoing scope for improving free cash flow generation.

Compounding Growth in 2026

· The Informa Growth Programme…At Informa's Capital Markets Day in November 2025, the Group committed to delivering consistent 5%+ underlying revenue growth over the next three years, faster underlying profit growth and 8%+ underlying EPS growth;

· Compounding underlying revenue growth…In 2026, we are targeting higher underlying revenue growth at 6%± (including prior year non-recurring LLM contracts and the establishment of inD), with B2B Events underlying growth of 7%+;

· Double-digit underlying earnings growth…In addition, we are targeting a sixth consecutive year of double-digit underlying adjusted earnings per share growth (excluding FX movements, biennial phasing and non-recurring LLM contracts);

· Strong 2026 visibility…Early trading supports these targets, with recurring visibility through forward booked subscriptions, exhibitor revenues and other advance contracts, delivering £1.5bn± of booked/committed revenues for 2026.

Consistent Shareholder Returns

· 2026 Share Buyback Programme…2025 Share Buyback Programme of £350m completed in December, with c.42.8m shares bought at an average share price of 817p; 2026 Share Buyback Programme launched in line with last year, with an initial minimum investment of £200m, commencing immediately, and scope for further buybacks through the year; 2025 year-end leverage is expected to be 2.4x net debt / EBITDA;

· Further dividend returns…Ongoing commitment to progressive dividends reflected in proposed 2025 ordinary dividend of 22p per share, up 10% year-on-year, which will be confirmed within the 2025 Full Year Results in March.

Conclusion

· Informa's strong performance in 2025, forward visibility and improving performance at Informa TechTarget in 2026, combined with the establishment of inD, leads to the increase in Group underlying revenue growth guidance to 6%±.

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Anthony Di Natale - Teneo

+44 (0) 7583 413254 / +44 (0) 7880 715975

 

About Britain's Most Admired Companies

Britain's Most Admired Companies is an annual study of corporate reputation run by Echo Research in partnership with the London Stock Exchange. The study recognises excellence across industry sectors, based on peer and analyst review of leading UK-listed companies. Find out more at: https://www.britainsmostadmired.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFFLLSIALIR
Date   Source Headline
17th Jan 20253:10 pmRNSDirector/PDMR Shareholding
13th Dec 202410:00 amRNSDirector Declaration
3rd Dec 20247:00 amRNSInforma TechTarget...scale in B2B Digital Services
19th Nov 20247:00 amRNSTen-Month Trading Update
18th Nov 20241:21 pmRNSStabilisation Notice
16th Oct 20249:49 amRNSStabilisation Notice
10th Oct 202410:05 amRNSHolding(s) in Company
9th Oct 20248:00 amRNSDe-listing and cancellation of trading of shares
9th Oct 20247:16 amRNSInforma 2025-2030: A Growth Platform
9th Oct 20247:00 amRNSScheme of Arrangement Becomes Effective
8th Oct 20245:14 pmRNSForm 8 (DD) - Ascential plc
8th Oct 202411:48 amRNSForm 8.3 - Ascential PLC
26th Sep 20245:05 pmRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSUpdate on the Hudson MX Sale Process
10th Sep 202411:53 amRNSHolding(s) in Company
9th Sep 20242:22 pmRNSForm 8.3 - Ascential plc
9th Sep 20247:00 amRNSSatisfaction of Conditions and Timetable Update
6th Sep 202412:00 pmRNSForm 8.3 - Ascential plc
5th Sep 202411:16 amRNSForm 8.3 - Ascential plc
5th Sep 20248:25 amRNSBoard Update
4th Sep 20243:51 pmRNSResults of Court Meeting and General Meeting
27th Aug 20244:03 pmRNSTransaction Update
12th Aug 20247:00 amRNSPublication of Scheme Document
2nd Aug 20243:49 pmRNSBlock listing Interim Review
1st Aug 202411:00 amRNSTotal Voting Rights
24th Jul 20242:57 pmRNSForm 8.3 - Ascential plc
24th Jul 20247:00 amRNSRecommended Cash Offer for Ascential plc
24th Jul 20247:00 amRNSHalf-year Report
24th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20245:35 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20242:15 pmRNSBoard Update
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 202411:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.